Orchid Pharma Ltd (ORCHIDPHAR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Orchid Pharma Ltd (ORCHIDPHAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3338
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, anti-diabetic products, nutritional supplements and various other products. It provides API such as cephalosporins-orals, cephalosporins-injectibles, veterinary products and non-antibiotics, among others. Orchid offers veterinary products, which include cefalonium, cefquinome sulphate, ceftiofur hydrochloride and ceftiofur sodium, among others. The company provides services such as process and pharma research, new drug discovery, pre-clinical research, biotech research, intellectual property management and contract research, among others. It has presence in the UK, South Africa, India, the US and Ukraine, among others. Orchid is headquartered in Chennai, Tamil Nadu, India.

Orchid Pharma Ltd (ORCHIDPHAR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orchid Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Nectar Lifesciences and Blackstone May Acquire Orchid Pharma 11
Partnerships 12
Orchid Chemicals & Pharma Enters Into Co-Development Agreement With Allecra Therapeutics 12
Licensing Agreements 13
Orchid Chemicals Plans To Enter Into Licensing Agreement With Pharma Companies 13
Asset Transactions 14
Hospira Healthcare Completes Acquisition of Manufacturing and R&D Facility from Orchid Chemicals & Pharma for USD218 Million 14
Acquisition 16
NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For US$14 Million 16
Orchid Pharma Ltd – Key Competitors 17
Orchid Pharma Ltd – Key Employees 18
Orchid Pharma Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
May 26, 2017: Orchid Pharma registers turnover of Rs. 766 crore in FY17 21
Corporate Communications 22
Jan 05, 2018: Orchid Pharma Announces Resignation of Directors 22
Legal and Regulatory 23
Jan 08, 2018: Orchid Pharma: Establishment Inspection Report from US FDA 23
Sep 21, 2017: Orchid Pharma receives Establishment Inspection Report from US FDA 24
Apr 18, 2017: Orchid Pharma Provides Update on Sriperumbudur Manufacturing Facility 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orchid Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orchid Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nectar Lifesciences and Blackstone May Acquire Orchid Pharma 11
Orchid Chemicals & Pharma Enters Into Co-Development Agreement With Allecra Therapeutics 12
Orchid Chemicals Plans To Enter Into Licensing Agreement With Pharma Companies 13
Hospira Healthcare Completes Acquisition of Manufacturing and R&D Facility from Orchid Chemicals & Pharma for USD218 Million 14
NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For US$14 Million 16
Orchid Pharma Ltd, Key Competitors 17
Orchid Pharma Ltd, Key Employees 18
Orchid Pharma Ltd, Other Locations 19
Orchid Pharma Ltd, Subsidiaries 19

List of Figures
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Orchid Pharma Ltd (ORCHIDPHAR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ok Tedi Mining Ltd:企業の戦略・SWOT・財務情報
    Ok Tedi Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Ok Tedi Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sun A. Kaken Co. Ltd.:企業の戦略・SWOT・財務情報
    Sun A. Kaken Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun A. Kaken Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sino-Ocean Group Holding Limited:企業の戦略・SWOT・財務情報
    Sino-Ocean Group Holding Limited - Strategy, SWOT and Corporate Finance Report Summary Sino-Ocean Group Holding Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Basware Oyj (BAS1V):企業の財務・戦略的SWOT分析
    Basware Oyj (BAS1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Transgene SA (TNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …
  • Sam Chun Dang Pharm Co Ltd (000250)-製薬・医療分野:企業M&A・提携分析
    Summary Sam Chun Dang Pharm Co Ltd (SCD) is a research and development company that discovers and develops drugs. The company offers products in the therapeutic areas of ophthalmology, cardiovasculars, endocrinology, gastrointestines, antibacterials, anti-fungals, antivirals, respiratory, antiinflam …
  • Tata Communications Ltd (TATACOMM):企業の財務・戦略的SWOT分析
    Tata Communications Ltd (TATACOMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • TAG Oil Ltd (TAO):企業の財務・戦略的SWOT分析
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas exploration company engaged in the production of crude oil and natural gas across Canada. The company owns and operates oil and gas properties in Surat Basin and Taranaki Basin. The Taranaki Basin is located to the North Island of New Zealand. The comp …
  • ThromboGenics NV (THR)-製薬・医療分野:企業M&A・提携分析
    Summary ThromboGenics NV (ThromboGenics) is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) …
  • Endotronix Inc-医療機器分野:企業M&A・提携分析
    Summary Endotronix Inc (Endotronix) is a medical device company that provides digital health solutions. The company offers wireless health monitoring solutions to congestive heart failure patients. It develops endotronix care management solution to communicate pressures that accurately measure cardi …
  • Sequana Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sequana Medical AG (Sequana Medical), formerly NovaShunt AG, is a commercial stage medical device company that offers automated implantable pump systems to monitor fluid balance within the body. The company designs, develops and commercializes alfapump, a fully implantable, programmable, tra …
  • KGHM Polska Miedz SA:企業の戦略・SWOT・財務情報
    KGHM Polska Miedz SA - Strategy, SWOT and Corporate Finance Report Summary KGHM Polska Miedz SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bashneft (BANE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • KemPharm Inc (KMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …
  • Zetro Aerospace Corporation Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Camel-IDS NV-製薬・医療分野:企業M&A・提携分析
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radiopharmaceutical drug for treatment of Her2 positive cancer. Its technology platform is based on …
  • Enerkem Inc:企業の戦略的SWOT分析
    Enerkem Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ortho-Clinical Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ortho-Clinical Diagnostics Inc (OCD), a subsidiary of The Carlyle Group L.P., is a provider of in vitro diagnostic products and services. The company designs, develops, manufactures and distributes in-vitro diagnostic products. It serves clinical laboratories by providing comprehensive solut …
  • TIBCO Software, Inc.:企業の戦略・SWOT・財務分析
    TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆